期刊文献+

灭活法研制乙肝表面抗原室内质控血清 被引量:7

Inactivated Method to Manufacture Internal Quality Control Serum of Hepatitis B Type Virus Surface Antigen(HBsAg)
下载PDF
导出
摘要 目的:用灭活法研制乙肝表面抗原(HBsAg)室内质控血清。方法:筛选HBsAg阳性血清,60℃加热1h进行灭活,同时与卫生部临床检验中心提供的HBsAg质控品比较,选取合适浓度的阳性血清作为ELISA法检测HBsAg的室内质控品。结果:该质控品定值为2 IU/ml和10 IU/ml。其稳定性实验表明:2-8℃3个月及-20℃保存6个月的含量无明显变化。均一性检测结果:瓶间不精密度为7.15%和8.97%。结论:60℃加热1h灭活法制备的质控品可以作为用于ELISA法检测HBsAg的室内质控。 Objective: To assess the efficiency of inactivated method to manufacture internal quality control serum of hepatitis B type virus surface antigen ( HBsAg ). Method: The HBsAg positive serum samples with good quality were collected and inactivated by bathing at 60℃ for 1 hour, then mixed and diluted to proper concentration with the reference of control serum provided by the national center for clinical laboratory ( NCCL), fractional packed in eppendolf tube and preserved in 2 -8℃ refrigerator for assessment detection by enzyme linked immunosorbent assay ( ELISA ). Result: The target titer value of the self - manufacture control serum was set to 2 IU/ml and 10 IU/ml respectively. Stability of these control serum was confirmed to preserving at 2 to 8℃ for 3 months and -20℃ for 6 months. Homogeneity test showed that the vail -to -vail imprecision was 5.53% and 8.97% respectively. Conclusion: These samples could be used as the internal quality control for HBsAg test with ELISA assay.
出处 《河北医学》 CAS 2009年第4期402-405,共4页 Hebei Medicine
基金 汕头市重点科技计划项目:汕府科[2006]82号
关键词 乙肝表面抗原(HBsAg) 室内质控 Hepatitis B virus surface antigen(HBsAg) Internal quality control
  • 相关文献

参考文献6

二级参考文献19

  • 1王露楠,李金明,邓巍,王忠芳.乙型肝炎病毒DNA定值冻干血清用于荧光定量聚合酶链反应测定的研究[J].中华检验医学杂志,2004,27(8):523-525. 被引量:9
  • 2Robert F.Moran,莫培生.室内质量控制和基本统计学[J].中华医学检验杂志,1996,19(1):49-51. 被引量:17
  • 3王露楠,吴健民,李金明,邓巍,王忠芳,申子瑜,陈文祥.丙型肝炎病毒核酸检测的国家标准物质的研制[J].中华检验医学杂志,2006,29(4):354-357. 被引量:40
  • 4周燕荣.医学检验统计学[M].重庆:科学技术文献出版社重庆分社,1990.. 被引量:4
  • 5[4]Adam, Uldall. Elements of A Temder for Ourchasing Costum - Made Serum. EQAnews, 1998,9: 10~ 11. 被引量:1
  • 6Saldanha J,Lelie N,Heath A.Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA.Vox Sanguinis,1999,76:149-158. 被引量:1
  • 7Saldanha J,Heath A,Aberham C,et al.World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays.Vox Sang,2005,88:202-204. 被引量:1
  • 8Saldanha J,Heath A,Lelie N,et al.Calibration of HCV Working reagents for NAT Assays against the HCV International Standard.Vox Sang,2000,78:217-224. 被引量:1
  • 9Jorgen PA,Neuwald PD.Standardized hepatitis C virus RNA panels for nucleic acid testing assays.J Clin Virol,2001,20:35-40. 被引量:1
  • 10Saldanha J,Heath A,Collaborative Study Group.Collaborative study to calibrate hepatitis C virus genotypes 2-6 against the HCV International Standard,96/790 (genotype 1).Vox Sang,2003,84:20-27. 被引量:1

共引文献93

同被引文献33

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部